Patent: 10,072,098

Summary for Patent: 10,072,098

Title:	Pseudomonas aeruginosa PCRV binding single variable domain antibodies
Abstract:	Polypeptides are provided that are capable of significantly inhibiting and/or neutralizing P aeruginosa. The polypeptides comprise two or more immunoglobulin single variable domains that are directed against the PcrV protein of P. aeruginosa, wherein the \"first\" immunoglobulin single variable domain and the \"second\" immunoglobulin single variable domain have different paratopes.
Inventor(s):	De Tavernier; Evelyn (Deurle, BE), Union; Ann (Aalter, BE), Dombrecht; Bruno (Heusden, BE), Hermans; Guy (Merelbeke, BE), Morizzo; Erika (Ghent, BE)
Assignee:	Ablynx N.V. (Ghent-Zwijnaarde, BE)
Application Number:	14/382,027
Patent Claims:	see list of patent claims

Details for Patent 10,072,098

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Grifols Therapeutics Llc	ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5	albumin (human)	For Injection	101138	October 21, 1942	10,072,098	2033-03-04
Takeda Pharmaceuticals U.s.a., Inc.	BUMINATE, FLEXBUMIN	albumin (human)	Injection	101452	March 03, 1954	10,072,098	2033-03-04
Csl Behring Ag	ALBURX	albumin (human)	Injection	102366	July 23, 1976	10,072,098	2033-03-04
Grifols Biologicals Llc	ALBUTEIN	albumin (human)	Injection	102478	August 15, 1978	10,072,098	2033-03-04
Grifols Biologicals Llc	ALBUTEIN	albumin (human)	Injection	102478	November 29, 2022	10,072,098	2033-03-04
Instituto Grifols, S.a.	HUMAN ALBUMIN GRIFOLS	albumin (human)	Injection	103352	February 17, 1995	10,072,098	2033-03-04
Instituto Grifols, S.a.	HUMAN ALBUMIN GRIFOLS	albumin (human)	Injection	103352	June 11, 2003	10,072,098	2033-03-04